Drug targeting and design

Many drug targets are localized to particular subcellular compartments. Yet current drug design strategies are focused on bioavailability and tissue targeting and rarely address drug delivery to specific intracellular compartments. Insights into how the cell traffics its constituents to these different cellular locations could improve drug design. The process of the design/discovery of drugs typically involves understanding the character of targets (e.g. enzyme, cell, tissues, etc) related to the disease, setting-up the concept of drug design, providing lead compounds (via traditional medicines, natural products, biological macromolecules, compound libraries, computational chemistry, etc.), and design and lead optimization by means of analyzing structure-activity-relationships. A deep understanding of this process in addition to the mode of action at a molecular level will help pharmacists with decisions on appropriate dosing and administration of medicines.

 

  • Track 1-1 Designing Drug-Delivery Nanoparticles
  • Track 2-2 Drug Targeting strategies
  • Track 3-3 Recent approaches to drug targeting
  • Track 4-4 Computer aided drug design
  • Track 5-5 Rational drug design

Related Conference of Pharmaceutical Sciences